Kenacort-A 40 - triamcinolone acetonide (Unlicensed version - possible alternative to the UK version Kenalog in short supply)

Kenacort-A 40 (triamcinolone acetonide) 40mg/1ml Ampoules 5 x 1ml (unlicensed version)

Indicated for:

Intramuscular: The intramuscular administration of Kenacort-A 40 Injection is indicated for systemic corticosteroid therapy in such conditions as allergic diseases, dermatoses, or generalised rheumatoid arthritis and other connective tissue disorders. Intramuscular administration is particularly valuable in such conditions when oral corticosteroid therapy is not feasible.

Intra-articular: Kenacort-A 40 Injection is indicated for intra-articular or intrasynovial administration, and for injections into tendon sheaths, as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in; synovitis of osteoarthritis; rheumatoid arthritis; acute and subacute bursitis; acute gouty arthritis; epicondylitis; acute nonspecific tenosynovitis; post-traumatic osteoarthritis.

Kenacort-A 40 is an import from Australia and is unlicensed in the United Kingdom, practitioners may choose to use when UK licenced version is in short supply.

Available on request.

Available on request.